Study S000723

Short-term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT01911468
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 36
Start: 2011-11
Primary completion: 2012-10
Lead sponsor: University Medical Centre Ljubljana
Conditions: PCOS; Obesity
Interventions: DRUG:metformin; DRUG:liraglutide; DRUG:metformin and liraglutide
Results posted: FALSE

Registered primary outcomes

The main outcome was change in body weight. [Patient's body weight was mesured at the base point and every four weeks during 12 weeks of clinical trial.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0013774	Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome. Jensterle M, Endocrine research	2015	Other trial	PMID 25330463 DOI	cites ClinicalTrials.gov:NCT01911468; registry reference DERIVED:25330463